Psychosocial and Human Factors During a Trial of a Hybrid Closed Loop System for Type 1 Diabetes Management
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Hybrid closed loop (HCL) systems are designed to automate insulin delivery to improve type 1 diabetes (T1D) outcomes and reduce user burden and distress. Because the systems only automate some aspects of diabetes care, psychosocial and human factors remain an important consideration in their use. Thus, we examined whether psychosocial and human factors (i.e., distress related to diabetes management, fear of hypoglycemia, and technology attitudes) would (1) change after using the system and (2) predict glycemic outcomes during the trial. SUBJECTS AND METHODS: Fourteen adults and 15 adolescents with T1D participated in a multisite clinical trial of an investigational version of the MiniMed™ 670G system (Medtronic, Northridge, CA) over 4 to 5 days in a semisupervised outpatient setting. Users completed surveys assessing psychosocial and human factors before beginning the HCL system and at the conclusion of the study. t-Tests and regression analyses were conducted to examine whether these factors changed following trial exposure to the HCL system and predicted glycemic outcomes during the trial. RESULTS: Diabetes management distress decreased and diabetes technology attitudes became more positive over the trial period. Fear of hypoglycemia did not change over the trial period. There was a trend toward greater pretrial management distress predicting less time in range during the trial, controlling for time in range before the trial. CONCLUSIONS: Results suggest that this system is promising for enhancing technology attitudes and reducing management distress. Psychosocial factors, such as management distress, may negatively impact glycemic outcomes and should be a priority area for further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Depression and poor glycemic control: a meta-analytic review of the literature.
Lustman, P. J., Anderson, R. J., Freedland, K. E., de Groot, M., Carney, R. M., & Clouse, R. E. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.934 · Cited by 1,854
Depression and Diabetes Treatment Nonadherence: A Meta-Analysis
Gonzalez, J. S., Peyrot, M., McCarl, L. A., Collins, E. M., Serpa, L., Mimiaga, M. J., & Safren, S. A. (2008) · Diabetes Care · doi:10.2337/dc08-1341 · Cited by 1,060 · cited 2×
“2,4,5,13,24,25 Management distress is modifi-able through behavioral health intervention 26,27 ; therefore, this result may have implications for future interventions to improve glycemic outcomes among people using HCL systems.”
Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes
Bergenstal, R. M., Garg, S., Weinzimer, S. A., Buckingham, B. A., Bode, B. W., Tamborlane, W. V., & Kaufman, F. R. (2016) · JAMA · doi:10.1001/jama.2016.11708 · Cited by 644
Self-citationGarg, S. K., Weinzimer, S. A., Tamborlane, W. V., Buckingham, B. A., Bode, B. W., Bailey, T. S., Brazg, R. L., Ilany, J., Slover, R. H., Anderson, S. M., et al. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0421 · Cited by 585
Self-citationWild, D., von Maltzahn, R., Brohan, E., Christensen, T., Clauson, P., & Gonder-Frederick, L. (2007) · Patient Education and Counseling · doi:10.1016/j.pec.2007.05.003 · Cited by 545
Understanding the sources of diabetes distress in adults with type 1 diabetes
Fisher, L., Polonsky, W. H., Hessler, D. M., Masharani, U., Blumer, I., Peters, A. L., Strycker, L. A., & Bowyer, V. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.01.012 · Cited by 414 · cited 2×
“2,4,5,13,24,25 Management distress is modifi-able through behavioral health intervention 26,27 ; therefore, this result may have implications for future interventions to improve glycemic outcomes among people using HCL systems.”
Depressive Symptoms in Children and Adolescents With Type 1 Diabetes
Hood, K. K., Huestis, S., Maher, A., Butler, D., Volkening, L., & Laffel, L. M. B. (2006) · Diabetes Care · doi:10.2337/dc06-0087 · Cited by 353
Self-citationPsychometric properties of the hypoglycemia fear survey-ii for adults with type 1 diabetes
Gonder-Frederick, L. A., Schmidt, K. M., Vajda, K. A., Greear, M. L., Singh, H., Shepard, J. A., & Cox, D. J. (2011) · Diabetes Care · doi:10.2337/dc10-1343 · Cited by 337
Tanenbaum, M. L., Hanes, S. J., Miller, K. M., Naranjo, D., Bensen, R., & Hood, K. K. (2017) · Diabetes Care · doi:10.2337/dc16-1536 · Cited by 296 · cited 1×
“2,4,5,13,24,25 Management distress is modifi-able through behavioral health intervention 26,27 ; therefore, this result may have implications for future interventions to improve glycemic outcomes among people using HCL systems.”
Self-citationREDEEM: A pragmatic trial to reduce diabetes distress
Fisher, L., Hessler, D., Glasgow, R. E., Arean, P. A., Masharani, U., Naranjo, D., & Strycker, L. A. (2013) · Diabetes Care · doi:10.2337/dc12-2493 · Cited by 266 · cited 1×
“2,4,5,13,24,25 Management distress is modifi-able through behavioral health intervention 26,27 ; therefore, this result may have implications for future interventions to improve glycemic outcomes among people using HCL systems.”
Self-citation
Cited by
One year clinical experience of the first commercial hybrid closed-loop system
Lal, R. A., Basina, M., Maahs, D. M., Hood, K., Buckingham, B., & Wilson, D. M. (2019) · Diabetes Care · doi:10.2337/dc19-0855 · Cited by 215
“Prior insulin delivery systems Animas 13 (9) 3 (8) 10 (10) Medtronic, older 62 (45) 19 (49) 43 (44) Medtronic 630G 37 (27) 13 (33) 24 (24) Omnipod 5 (4) 1 (3) 4 (4) Roche 1 (1) 0 (0) 1 (1) Tandem 4 (3) 0 (0) 4 (4) Multiple daily injections 4 (3) 1 (3) 3 (3) Other 11 (8) 2 (5) 9 (9)”
Self-citationRacial–Ethnic Disparities in Diabetes Technology use Among Young Adults with Type 1 Diabetes
Agarwal, S., Schechter, C., Gonzalez, J., & Long, J. A. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0338 · Cited by 182
Garg, S. K., Grunberger, G., Weinstock, R., Lawson, M. L., Hirsch, I. B., DiMeglio, L. A., Pop-Busui, R., Philis-Tsimikas, A., Kipnes, M., Liljenquist, D. R., et al. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0421 · Cited by 63
“…insulin delivery therapy use and the reported improvement in A1C, %TIR, %TBR, and %TAR with different systems, 23 there have been prospective 20,24–28 and retrospective 29,30 studies that assessed psychosocial participant-reported outcomes (PROs) compared with control (either MDI, CSII, or SAP…”
Self-citationDevelopment and evaluation of the Flourish Diabetes Programme
Kruger, S., Deacon, E., van Rensburg, E., & Segal, D. (2025) · Health SA Gesondheid · doi:10.4102/hsag.v30i0.2923 · Cited by 1
“As the closed-loop system only automates parts of diabetes care, psychological factors are an important consideration in the use of such a system, because ultimate success with the system depends on the engagement of the person using the technology (Adams et al. 2018).”
Metadata
- Authors
- Adams, R. N., Tanenbaum, M. L., Hanes, S. J., Ambrosino, J. M., Ly, T. T., Maahs, D. M., Naranjo, D., Walders-Abramson, N., Weinzimer, S. A., Buckingham, B. A., & Hood, K. K.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2018-10
- Volume
- 20
- Issue
- 10
- Pages
- 648-653
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W2890283435
- Cited by
- 43
- References
- 14
- FWCI
- 2.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.